Holen Sie sich die Stockscreener-App
4.6637
2.02%
-0.0963
Schlusskurs vom Vortag:
$4.76
Offen:
$4.78
24-Stunden-Volumen:
223.31K
Relative Volume:
0.35
Marktkapitalisierung:
$218.97M
Einnahmen:
$138.90M
Nettoeinkommen (Verlust:
$-107.15M
KGV:
-1.8483
EPS:
-2.5232
Netto-Cashflow:
$-79.85M
1W Leistung:
-7.83%
1M Leistung:
-18.75%
6M Leistung:
-3.04%
1J Leistung:
-34.41%
1-Tages-Spanne:
$4.60
$4.85
1-Wochen-Bereich:
$4.60
$5.28
52-Wochen-Spanne:
$4.05
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Firmenname
Quanterix Corp
Sektor
Branche
Telefon
617-301-9400
Adresse
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
4.665 | 223.43M | 138.90M | -107.15M | -79.85M | -2.5232 |
|
ABT
Abbott Laboratories
|
108.47 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.21 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.24 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.50 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.93 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-09-25 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-15 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-08-09 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Hochstufung | Goldman | Sell → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Sell |
Alle ansehen
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
Risk Report: Whats the MACD signal for Quanterix CorporationRate Cut & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com
Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com
William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Quanterix Q4 Earnings Call Highlights - Defense World
Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st
Quanterix (QTRX) Q4 2025 Earnings Call Transcript - AOL.com
Quanterix Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus
Quanterix Q4 2025 Earnings Call Transcript - MarketBeat
Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Exceeds Q4 Revenue Expectations with Strong Per - GuruFocus
Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative
Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Quanterix Corporation 8-K Filing Analysis - TradingView
Quanterix Earnings Report: Q4 Overview - Benzinga
Alzheimer’s blood test heads to 15,000 community events a year - Stock Titan
Quanterix (QTRX) Set to Announce Q4 Earnings with Revenue Growth Expected - GuruFocus
Quanterix (QTRX) to Release Earnings on Monday - Defense World
Quanterix Corp expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Earnings Outlook For Quanterix - Benzinga
Quanterix Corp (QTRX) Q4 2025 Earnings Report Preview: What To L - GuruFocus
Quanterix to Participate in Upcoming Investor Conferences - ChartMill
Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX - Defense World
Biomarker firm Quanterix plans two March investor webcasts - Stock Titan
QTRX Should I Buy - Intellectia AI
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Investors can hear Quanterix 2025 results discussed on Mar. 2 call - Stock Titan
Quanterix (NASDAQ:QTRX) Shares Up 0.7%Time to Buy? - MarketBeat
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test - Clinical Lab Products
With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing - Yahoo Finance
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN
Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView
Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus
Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com
Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan
What’s the MACD signal for Quanterix CorporationWeekly Volume Report & Long-Term Growth Stock Strategies - mfd.ru
Quanterix (NASDAQ:QTRX) Trading Down 3.6%Here's What Happened - MarketBeat
Quanterix (NASDAQ:QTRX) Trading Down 3.6% – Here’s What Happened - Defense World
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Study finds multi-biomarker approach improves Alzheimer’s risk assessment - Investing.com
15-year brain study: blood test combo better flags Alzheimer’s risk - Stock Titan
Finanzdaten der Quanterix Corp-Aktie (QTRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Quanterix Corp-Aktie (QTRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| WALT DAVID R | Director |
Jun 13 '25 |
Buy |
6.14 |
123,990 |
760,803 |
1,866,933 |
| WALT DAVID R | Director |
Jun 12 '25 |
Buy |
6.23 |
36,010 |
224,166 |
1,742,943 |
| Toloue Masoud | President & CEO |
Jun 09 '25 |
Buy |
5.42 |
45,900 |
248,723 |
518,922 |
| WALT DAVID R | Director |
Jun 06 '25 |
Buy |
5.43 |
131,869 |
716,576 |
1,628,802 |
| WALT DAVID R | Director |
Jun 09 '25 |
Buy |
5.34 |
78,131 |
417,220 |
1,706,933 |
| DONNELLY WILLIAM P | Director |
Jun 06 '25 |
Buy |
5.44 |
93,113 |
506,348 |
139,094 |
0.93%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):